Continuous ACE Inhibitor Use Is Associated With Improved Perioperative and Long-term Mortality Benefit in Patients Undergoing Lower Extremity Bypass for Peripheral Arterial Disease

Isaac Naazie,Jonathan Unkart,Isibor Arhuidese,Jeffrey J Siracuse,Mahmoud B Malas

doi:10.1016/j.jvs.2021.06.376

Continuous ACE Inhibitor Use Is Associated With Improved Perioperative and Long-term Mortality Benefit in Patients Undergoing Lower Extremity Bypass for Peripheral Arterial Disease

Isaac Naazie, Jonathan Unkart + Show 3 more

Open Access

https://doi.org/10.1016/j.jvs.2021.06.376

Copy DOI

Journal: Journal of vascular surgery

Publication Date: Aug 20, 2021

Affiliation: University of California, San Diego, State University of New York, University of South Florida, Boston University

#Bypass For Peripheral Arterial Disease #Angiotensin-converting Enzyme Inhibitor Use + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Different angiotensin-converting enzyme inhibitor (ACEI) use patterns exist in relation to patients undergoing lower extremity bypass (LEB) for peripheral arterial occlusive disease (PAD). We aimed to study the association of the different ACEI use patterns with LEB for PAD to determine which pattern is associated with perioperative and long-term mortality benefit.

Full Text